Back to Search
Start Over
Gefitinib plus docetaxel in non-small-cell lung cancer.
- Source :
-
Lancet (London, England) [Lancet] 2009 Feb 14; Vol. 373 (9663), pp. 541; author reply 542. - Publication Year :
- 2009
- Subjects :
- Biomarkers, Tumor genetics
Carcinoma, Non-Small-Cell Lung genetics
Carcinoma, Non-Small-Cell Lung mortality
Docetaxel
ErbB Receptors genetics
Gefitinib
Humans
Lung Neoplasms genetics
Lung Neoplasms mortality
Randomized Controlled Trials as Topic
Antineoplastic Agents therapeutic use
Carcinoma, Non-Small-Cell Lung drug therapy
ErbB Receptors drug effects
Lung Neoplasms drug therapy
Protein Kinase Inhibitors therapeutic use
Quinazolines therapeutic use
Taxoids therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1474-547X
- Volume :
- 373
- Issue :
- 9663
- Database :
- MEDLINE
- Journal :
- Lancet (London, England)
- Publication Type :
- Editorial & Opinion
- Accession number :
- 19217979
- Full Text :
- https://doi.org/10.1016/S0140-6736(09)60193-8